about
Propranolol blocks cardiac and neuronal voltage-gated sodium channelsThird-generation beta-adrenoceptor antagonists in the treatment of hypertension and heart failure{Beta}-blocker drugs mediate calcium signaling in native central nervous system neurons by {beta}-arrestin-biased agonismSleep in the Intensive Care Unit: A Review.Effects of early albuterol (salbutamol) administration on the development of posttraumatic stress symptomsBeta-adrenergic modulation of tremor and corticomuscular coherence in humans.Permeability of the blood-brain barrier for atenolol studied by positron emission tomography.Vascular complications and gene therapy.Treatment of infantile haemangiomas: recommendations of a European expert group.Neurocognitive costs and benefits of psychotropic medications in older adults.Nebivolol: pharmacologic profile of an ultraselective, vasodilatory beta1-blocker.β-blockers and their mortality benefits: underprescribed in heart failure and chronic obstructive pulmonary disease.Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management.Pharmacokinetics of selective β1-adrenergic blocking agents: prescribing implications.Headache, drugs and sleep.Propranolol and central nervous system function: potential implications for paediatric patients with infantile haemangiomas.Risk of insomnia with non-vitamin K oral anticoagulants: systematic review and meta-analysis.Beta-blocker use and fall risk in older individuals: Original results from two studies with meta-analysis.Synthesis and Determination of Physicochemical Properties of New 3-(4-Arylpiperazin-1-yl)-2-hydroxypropyl 4-Alkoxyethoxybenzoates.Ciprofloxacin and sparfloxacin penetration into human brain tissue and their activity as antagonists of GABAA receptor of rat vagus nerve.Melatonin and sleep in humans.Metoprolol-induced visual hallucinations: a case seriesEvidence for the involvement of peripheral β-adrenoceptors in delayed liquid gastric emptying induced by dipyrone, 4-aminoantipyrine, and antipyrine in ratsEffects of intravenous propranolol on heat pain sensitivity in healthy men.Combined beta-adrenergic and cholinergic antagonism produces behavioral and cognitive impairments in the water maze: implications for Alzheimer disease and pharmacotherapy with beta-adrenergic antagonists.Noradrenergic blockade and numeric working memory in humans.Preoperative medication use and postoperative delirium: a systematic review.Quantification of Bisoprolol and Metoprolol in Simultaneous Human Serum and Cerebrospinal Fluid Samples.Ivabradine and nightmares: a previously unreported adverse reaction.Central nervous system effects of HMG CoA reductase inhibitors: lovastatin and pravastatin on sleep and cognitive performance in patients with hypercholesterolemia.[Substance-induced sleep disorders and abuse of hypnotics].Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay
P2860
Q21129289-EDA9C778-0A17-48E4-8159-F4872BB935B8Q26822825-FB18392D-E553-43FF-AF53-5F2FF5A141E5Q28582523-82736822-FC60-4271-B06F-726933D2A98EQ30561410-EFEB6F19-16DF-4D59-BF0B-87E8ADD91AB2Q34137835-62496793-C929-46C7-807A-023FD358314BQ34489866-DB1E66F2-40E7-4408-996A-92D53FE4BF86Q34543317-93459202-8592-46AE-A146-8C09793E3002Q35116151-AAC868DC-5C4C-4D32-8B20-E14E56910A17Q35645474-556E94AA-0C5E-41A5-9E79-A78D1C82E64FQ37001163-2CE8610E-20F8-4C24-AD3C-A684253B6FB2Q37033656-37BFCA76-9E35-4023-BB67-6DA47EE54311Q37822723-8174A1BA-3274-4C04-9BD9-B7C2012C13CDQ38179262-30EE1986-1F9A-4727-860F-9EB8A3108300Q38226352-FECC375D-2D24-4A90-A30D-1B0FF7CF2612Q38233015-A766E58D-F2E3-40B2-8C4B-DE589AF93D45Q38245087-80A9EC56-D414-4053-8254-DF2B719A07FAQ38331661-DA950C81-9E8F-499B-97F3-5762E5A520B2Q38739070-073B0E5B-DA2D-4C25-904F-52DC41AA3CCBQ39110578-428E9579-7EF6-4759-BB90-CFAC622C6057Q39867096-DC1D3DCD-61D8-4B6F-B3E4-0E14BBE161B4Q40775591-13A98F41-B8BF-4959-8FE5-684C5E9A4E0FQ42594863-6B348318-CD54-4AFC-9A26-3CB80AF5C929Q42838917-2CE13E86-931B-4C14-BC3F-CB3604C15E2CQ43688833-8FD13593-203C-4255-BED5-A5C11218A958Q44407082-8EC56878-7A3F-43EC-8E18-43806B94B8DEQ45238691-799436AA-0A59-4DC6-BBA9-3FEB2942E3C9Q47126977-37A6D6C7-918A-4ECA-B4D1-950315A91FE5Q47683167-637715BB-4BB0-48FA-957A-0878744C1739Q48296314-D16AE849-844D-40FC-AD3E-B799327E1826Q48832403-56DB25C3-5F96-4B4A-9AE6-09C43A4AB8AFQ52618758-6BAADEBE-710C-4BAD-9EF5-7ACDC9C39DC6Q57296260-5DC3C0DD-26E6-4CC3-9C1B-B86CFF39200A
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1990
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Beta-blockers and central nervous system side effects.
@en
Beta-blockers and central nervous system side effects.
@nl
type
label
Beta-blockers and central nervous system side effects.
@en
Beta-blockers and central nervous system side effects.
@nl
prefLabel
Beta-blockers and central nervous system side effects.
@en
Beta-blockers and central nervous system side effects.
@nl
P1476
Beta-blockers and central nervous system side effects.
@en
P2093
Cruickshank JM
P304
P356
10.1016/0163-7258(90)90092-G
P577
1990-01-01T00:00:00Z